Spinal Fusion Device Market (By Product: Thoracolumbar Devices, Cervical Fixation Devices; By Disease Type: Degenerative Disc, Complex Deformity, Trauma & Fractures, Others; By Surgery: Open spine surgery, Minimally Invasive Spine Surgery; By End-user: Hospitals, Specialty Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Spinal Fusion Device Market, By Product

7.1.  Spinal Fusion Device Market, by Product, 2020-2030

7.1.1.    Thoracolumbar Devices   

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Cervical Fixation Devices 

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Interbody Fusion Devices

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Spinal Fusion Device Market, By Disease Type

8.1.  Spinal Fusion Device Market, by Disease Type, 2020-2030

8.1.1.    Degenerative Disc

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Complex Deformity

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Trauma & Fractures

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Others

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Spinal Fusion Device Market, By Surgery

9.1.  Spinal Fusion Device Market, by Surgery, 2020-2030

9.1.1.    Open spine surgery

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Minimally Invasive Spine Surgery

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Spinal Fusion Device Market, By End-user

10.1.        Spinal Fusion Device Market, by End-user, 2020-2030

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Specialty Clinics

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Others

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Spinal Fusion Device Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2030)

11.1.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.1.3.  Market Revenue and Forecast, by Surgery (2016-2030)

11.1.4.  Market Revenue and Forecast, by End-user (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.1.5.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.1.6.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2030)

11.2.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.3.  Market Revenue and Forecast, by Surgery (2016-2030)

11.2.4.  Market Revenue and Forecast, by End-user (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.2.5.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.2.6.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.2.7.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.2.8.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2030)

11.3.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.3.  Market Revenue and Forecast, by Surgery (2016-2030)

11.3.4.  Market Revenue and Forecast, by End-user (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.3.5.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.3.6.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.3.7.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.3.8.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2030)

11.4.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.3.  Market Revenue and Forecast, by Surgery (2016-2030)

11.4.4.  Market Revenue and Forecast, by End-user (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.4.5.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.4.6.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.4.7.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.4.8.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2030)

11.5.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.5.3.  Market Revenue and Forecast, by Surgery (2016-2030)

11.5.4.  Market Revenue and Forecast, by End-user (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.5.5.4.      Market Revenue and Forecast, by End-user (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Surgery (2016-2030)

11.5.6.4.      Market Revenue and Forecast, by End-user (2016-2030)

Chapter 12.  Company Profiles

12.1.              Johnson & Johnson Services, Inc. (DePuy Synthes)

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Stryker

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Zimmer Biomet

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Orthofix Medical, Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              B. Braun Melsungen AG

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Medtronic

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              NuVasive, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Globus Medical

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              ATEC Spine, Inc

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Captiva Spine, Inc

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           SeaSpine

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Spinal Elements, Inc.

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Spine Wave, Inc.

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           Spineology, Inc.

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

12.15.           Xtant Medical Holdings, Inc.

12.15.1.               Company Overview

12.15.2.               Product Offerings

12.15.3.               Financial Performance

12.15.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:38333
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:August 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers